Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

This study has been completed.
Information provided by (Responsible Party):
LG Life Sciences Identifier:
First received: June 7, 2012
Last updated: February 26, 2013
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)